APO Research

APO RESEARCH · REPORT

Loratadine API

Selected research

Market Structure

Global Loratadine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Loratadine API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Loratadine API include Shenzhen Salubris Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Merck Group, Mylan, Shaanxi Hanjiang, Changzhou Yabang, Changzhou Fangyuan Pharmaceutical, Vasudha Pharma Chem and Ultratech India Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Loratadine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Loratadine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Loratadine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Loratadine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Loratadine API Segment by Company

Shenzhen Salubris Pharmaceuticals

Shenzhen Haibin Pharmaceutical

Merck Group

Mylan

Shaanxi Hanjiang

Changzhou Yabang

Changzhou Fangyuan Pharmaceutical

Vasudha Pharma Chem

Ultratech India Limited

Morepen

Inke, S.A.

Hetero Drugs Ltd

Cadila Pharmaceuticals

Argon Drugs

Loratadine API Segment by Type

Pharmaceutical Standards Grade

EP Standards Grade

USP Standards Grade

Others

Loratadine API Segment by Application

Loratadine Syrup

Loratadine Tablet

Loratadine Capsules

Dry Suspension

Others

Loratadine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Loratadine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Loratadine API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Loratadine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Loratadine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Loratadine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Loratadine API Industry Trends Table 2. Loratadine API Industry Drivers Table 3. Loratadine API Industry Opportunities and Challenges Table 4. Loratadine API Industry Restraints Table 5. Global Loratadine API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Loratadine API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Loratadine API Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Loratadine API Sales Market Share by Manufacturers Table 9. Global Loratadine API Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Loratadine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Loratadine API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Loratadine API Manufacturers, Product Type & Application Table 13. Global Loratadine API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Loratadine API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pharmaceutical Standards Grade Table 17. Major Manufacturers of EP Standards Grade Table 18. Major Manufacturers of USP Standards Grade Table 19. Major Manufacturers of Others Table 20. Global Loratadine API Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 21. Global Loratadine API Sales by Type (2021-2026) & (k tons) Table 22. Global Loratadine API Sales by Type (2027-2032) & (k tons) Table 23. Global Loratadine API Sales Market Share by Type (2021-2026) Table 24. Global Loratadine API Sales Market Share by Type (2027-2032) Table 25. Global Loratadine API Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 26. Global Loratadine API Revenue by Type (2021-2026) & (k tons) Table 27. Global Loratadine API Revenue by Type (2027-2032) & (k tons) Table 28. Global Loratadine API Revenue Market Share by Type (2021-2026) Table 29. Global Loratadine API Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Loratadine Syrup Table 31. Major Manufacturers of Loratadine Tablet Table 32. Major Manufacturers of Loratadine Capsules Table 33. Major Manufacturers of Dry Suspension Table 34. Major Manufacturers of Others Table 35. Global Loratadine API Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 36. Global Loratadine API Sales by Application (2021-2026) & (k tons) Table 37. Global Loratadine API Sales by Application (2027-2032) & (k tons) Table 38. Global Loratadine API Sales Market Share by Application (2021-2026) Table 39. Global Loratadine API Sales Market Share by Application (2027-2032) Table 40. Global Loratadine API Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 41. Global Loratadine API Revenue by Application (2021-2026) & (k tons) Table 42. Global Loratadine API Revenue by Application (2027-2032) & (k tons) Table 43. Global Loratadine API Revenue Market Share by Application (2021-2026) Table 44. Global Loratadine API Revenue Market Share by Application (2027-2032) Table 45. Global Loratadine API Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 46. Global Loratadine API Sales by Region (2021-2026) & (k tons) Table 47. Global Loratadine API Sales Market Share by Region (2021-2026) Table 48. Global Loratadine API Sales Forecasted by Region (2027-2032) & (k tons) Table 49. Global Loratadine API Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 51. North America Loratadine API Sales by Country (2021-2026) & (k tons) Table 52. North America Loratadine API Sales by Country (2027-2032) & (k tons) Table 53. Europe Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. Europe Loratadine API Sales by Country (2021-2026) & (k tons) Table 55. Europe Loratadine API Sales by Country (2027-2032) & (k tons) Table 56. Asia Pacific Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. Asia Pacific Loratadine API Sales by Country (2021-2026) & (k tons) Table 58. Asia Pacific Loratadine API Sales by Country (2027-2032) & (k tons) Table 59. South America, Middle East and Africa Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 60. South America, Middle East and Africa Loratadine API Sales by Country (2021-2026) & (k tons) Table 61. South America, Middle East and Africa Loratadine API Sales by Country (2027-2032) & (k tons) Table 62. Global Loratadine API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Loratadine API Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Loratadine API Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Loratadine API Revenue Market Share by Region (2021-2026) Table 66. Global Loratadine API Revenue Market Share by Region (2027-2032) Table 67. Shenzhen Salubris Pharmaceuticals Company Information Table 68. Shenzhen Salubris Pharmaceuticals Business Overview Table 69. Shenzhen Salubris Pharmaceuticals Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Shenzhen Salubris Pharmaceuticals Loratadine API Product Portfolio Table 71. Shenzhen Salubris Pharmaceuticals Recent Development Table 72. Shenzhen Haibin Pharmaceutical Company Information Table 73. Shenzhen Haibin Pharmaceutical Business Overview Table 74. Shenzhen Haibin Pharmaceutical Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Shenzhen Haibin Pharmaceutical Loratadine API Product Portfolio Table 76. Shenzhen Haibin Pharmaceutical Recent Development Table 77. Merck Group Company Information Table 78. Merck Group Business Overview Table 79. Merck Group Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Merck Group Loratadine API Product Portfolio Table 81. Merck Group Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Mylan Loratadine API Product Portfolio Table 86. Mylan Recent Development Table 87. Shaanxi Hanjiang Company Information Table 88. Shaanxi Hanjiang Business Overview Table 89. Shaanxi Hanjiang Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Shaanxi Hanjiang Loratadine API Product Portfolio Table 91. Shaanxi Hanjiang Recent Development Table 92. Changzhou Yabang Company Information Table 93. Changzhou Yabang Business Overview Table 94. Changzhou Yabang Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Changzhou Yabang Loratadine API Product Portfolio Table 96. Changzhou Yabang Recent Development Table 97. Changzhou Fangyuan Pharmaceutical Company Information Table 98. Changzhou Fangyuan Pharmaceutical Business Overview Table 99. Changzhou Fangyuan Pharmaceutical Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Changzhou Fangyuan Pharmaceutical Loratadine API Product Portfolio Table 101. Changzhou Fangyuan Pharmaceutical Recent Development Table 102. Vasudha Pharma Chem Company Information Table 103. Vasudha Pharma Chem Business Overview Table 104. Vasudha Pharma Chem Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Vasudha Pharma Chem Loratadine API Product Portfolio Table 106. Vasudha Pharma Chem Recent Development Table 107. Ultratech India Limited Company Information Table 108. Ultratech India Limited Business Overview Table 109. Ultratech India Limited Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Ultratech India Limited Loratadine API Product Portfolio Table 111. Ultratech India Limited Recent Development Table 112. Morepen Company Information Table 113. Morepen Business Overview Table 114. Morepen Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Morepen Loratadine API Product Portfolio Table 116. Morepen Recent Development Table 117. Inke, S.A. Company Information Table 118. Inke, S.A. Business Overview Table 119. Inke, S.A. Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Inke, S.A. Loratadine API Product Portfolio Table 121. Inke, S.A. Recent Development Table 122. Hetero Drugs Ltd Company Information Table 123. Hetero Drugs Ltd Business Overview Table 124. Hetero Drugs Ltd Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Hetero Drugs Ltd Loratadine API Product Portfolio Table 126. Hetero Drugs Ltd Recent Development Table 127. Cadila Pharmaceuticals Company Information Table 128. Cadila Pharmaceuticals Business Overview Table 129. Cadila Pharmaceuticals Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Cadila Pharmaceuticals Loratadine API Product Portfolio Table 131. Cadila Pharmaceuticals Recent Development Table 132. Argon Drugs Company Information Table 133. Argon Drugs Business Overview Table 134. Argon Drugs Loratadine API Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Argon Drugs Loratadine API Product Portfolio Table 136. Argon Drugs Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Loratadine API Distributors List Table 140. Loratadine API Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Loratadine API Product Image Figure 2. Global Loratadine API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Loratadine API Market Size (2021-2032) & (US$ Million) Figure 4. Global Loratadine API Sales (2021-2032) & (k tons) Figure 5. Global Loratadine API Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Loratadine API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pharmaceutical Standards Grade Image Figure 9. EP Standards Grade Image Figure 10. USP Standards Grade Image Figure 11. Others Image Figure 12. Global Loratadine API Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 13. Global Loratadine API Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Loratadine API Sales Market Share by Type (2021-2032) Figure 15. Global Loratadine API Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 16. Global Loratadine API Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Loratadine API Revenue Market Share by Type (2021-2032) Figure 18. Loratadine Syrup Image Figure 19. Loratadine Tablet Image Figure 20. Loratadine Capsules Image Figure 21. Dry Suspension Image Figure 22. Others Image Figure 23. Global Loratadine API Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 24. Global Loratadine API Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Loratadine API Sales Market Share by Application (2021-2032) Figure 26. Global Loratadine API Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 27. Global Loratadine API Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Loratadine API Revenue Market Share by Application (2021-2032) Figure 29. North America Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 30. North America Loratadine API Sales Market Share by Country (2021-2032) Figure 31. U.S. Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 32. Canada Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 33. Mexico Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 34. Europe Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 35. Europe Loratadine API Sales Market Share by Country (2021-2032) Figure 36. Germany Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 37. France Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 38. U.K. Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 39. Italy Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 40. Netherlands Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Asia Pacific Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 42. Asia Pacific Loratadine API Sales Market Share by Country (2021-2032) Figure 43. China Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 44. Japan Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 45. South Korea Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 46. Southeast Asia Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 47. India Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 48. Australia Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 49. South America, Middle East and Africa Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 50. South America, Middle East and Africa Loratadine API Sales Market Share by Country (2021-2032) Figure 51. Brazil Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 52. South Africa Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 53. Saudi Arabia Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Turkey Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Argentina Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 56. UAE Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 57. Egypt Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 58. Chile Loratadine API Sales and Growth Rate (2021-2032) & (k tons) Figure 59. Global Loratadine API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Loratadine API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Loratadine API Revenue (2021-2032) & (US$ Million) Figure 62. North America Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Loratadine API Revenue (2021-2032) & (US$ Million) Figure 64. Europe Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Loratadine API Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Loratadine API Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Loratadine API Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Loratadine API Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Standards Grade
  • EP Standards Grade
  • USP Standards Grade
  • Others
Applications
  • Loratadine Syrup
  • Loratadine Tablet
  • Loratadine Capsules
  • Dry Suspension
  • Others
Companies covered
  • Shenzhen Salubris Pharmaceuticals
  • Shenzhen Haibin Pharmaceutical
  • Merck Group
  • Mylan
  • Shaanxi Hanjiang
  • Changzhou Yabang
  • Changzhou Fangyuan Pharmaceutical
  • Vasudha Pharma Chem
  • Ultratech India Limited
  • Morepen
  • Inke, S.A.
  • Hetero Drugs Ltd
  • Cadila Pharmaceuticals
  • Argon Drugs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Loratadine API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Loratadine API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Loratadine API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Loratadine API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Loratadine API Market Dynamics
  1. 2.1 Loratadine API Industry Trends
  2. 2.2 Loratadine API Industry Drivers
  3. 2.3 Loratadine API Industry Opportunities and Challenges
  4. 2.4 Loratadine API Industry Restraints
3 Loratadine API Market by Manufacturers
  1. 3.1 Global Loratadine API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Loratadine API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Loratadine API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Loratadine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Loratadine API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Loratadine API Manufacturers, Product Type & Application
  7. 3.7 Global Loratadine API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Loratadine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Loratadine API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Loratadine API Tier 1, Tier 2, and Tier 3
4 Loratadine API Market by Type
  1. 4.1 Loratadine API Type Introduction
  2. 4.1.1 Pharmaceutical Standards Grade
  3. 4.1.2 EP Standards Grade
  4. 4.1.3 USP Standards Grade
  5. 4.1.4 Others
  6. 4.2 Global Loratadine API Sales by Type
  7. 4.2.1 Global Loratadine API Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Loratadine API Sales by Type (2021-2032)
  9. 4.2.3 Global Loratadine API Sales Market Share by Type (2021-2032)
  10. 4.3 Global Loratadine API Revenue by Type
  11. 4.3.1 Global Loratadine API Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Loratadine API Revenue by Type (2021-2032)
  13. 4.3.3 Global Loratadine API Revenue Market Share by Type (2021-2032)
5 Loratadine API Market by Application
  1. 5.1 Loratadine API Application Introduction
  2. 5.1.1 Loratadine Syrup
  3. 5.1.2 Loratadine Tablet
  4. 5.1.3 Loratadine Capsules
  5. 5.1.4 Dry Suspension
  6. 5.1.5 Others
  7. 5.2 Global Loratadine API Sales by Application
  8. 5.2.1 Global Loratadine API Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Loratadine API Sales by Application (2021-2032)
  10. 5.2.3 Global Loratadine API Sales Market Share by Application (2021-2032)
  11. 5.3 Global Loratadine API Revenue by Application
  12. 5.3.1 Global Loratadine API Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Loratadine API Revenue by Application (2021-2032)
  14. 5.3.3 Global Loratadine API Revenue Market Share by Application (2021-2032)
6 Global Loratadine API Sales by Region
  1. 6.1 Global Loratadine API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Loratadine API Sales by Region (2021-2032)
  3. 6.2.1 Global Loratadine API Sales by Region (2021-2026)
  4. 6.2.2 Global Loratadine API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Loratadine API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Loratadine API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Loratadine API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Loratadine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Loratadine API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Loratadine API Revenue by Region
  1. 7.1 Global Loratadine API Revenue by Region
  2. 7.1.1 Global Loratadine API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Loratadine API Revenue by Region (2021-2026)
  4. 7.1.3 Global Loratadine API Revenue by Region (2027-2032)
  5. 7.1.4 Global Loratadine API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Loratadine API Revenue (2021-2032)
  8. 7.2.2 North America Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Loratadine API Revenue (2021-2032)
  11. 7.3.2 Europe Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Loratadine API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Loratadine API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Loratadine API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shenzhen Salubris Pharmaceuticals
  2. 8.1.1 Shenzhen Salubris Pharmaceuticals Company Information
  3. 8.1.2 Shenzhen Salubris Pharmaceuticals Business Overview
  4. 8.1.3 Shenzhen Salubris Pharmaceuticals Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shenzhen Salubris Pharmaceuticals Loratadine API Product Portfolio
  6. 8.1.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  7. 8.2 Shenzhen Haibin Pharmaceutical
  8. 8.2.1 Shenzhen Haibin Pharmaceutical Company Information
  9. 8.2.2 Shenzhen Haibin Pharmaceutical Business Overview
  10. 8.2.3 Shenzhen Haibin Pharmaceutical Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shenzhen Haibin Pharmaceutical Loratadine API Product Portfolio
  12. 8.2.5 Shenzhen Haibin Pharmaceutical Recent Developments
  13. 8.3 Merck Group
  14. 8.3.1 Merck Group Company Information
  15. 8.3.2 Merck Group Business Overview
  16. 8.3.3 Merck Group Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Group Loratadine API Product Portfolio
  18. 8.3.5 Merck Group Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Loratadine API Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Shaanxi Hanjiang
  26. 8.5.1 Shaanxi Hanjiang Company Information
  27. 8.5.2 Shaanxi Hanjiang Business Overview
  28. 8.5.3 Shaanxi Hanjiang Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shaanxi Hanjiang Loratadine API Product Portfolio
  30. 8.5.5 Shaanxi Hanjiang Recent Developments
  31. 8.6 Changzhou Yabang
  32. 8.6.1 Changzhou Yabang Company Information
  33. 8.6.2 Changzhou Yabang Business Overview
  34. 8.6.3 Changzhou Yabang Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Changzhou Yabang Loratadine API Product Portfolio
  36. 8.6.5 Changzhou Yabang Recent Developments
  37. 8.7 Changzhou Fangyuan Pharmaceutical
  38. 8.7.1 Changzhou Fangyuan Pharmaceutical Company Information
  39. 8.7.2 Changzhou Fangyuan Pharmaceutical Business Overview
  40. 8.7.3 Changzhou Fangyuan Pharmaceutical Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Changzhou Fangyuan Pharmaceutical Loratadine API Product Portfolio
  42. 8.7.5 Changzhou Fangyuan Pharmaceutical Recent Developments
  43. 8.8 Vasudha Pharma Chem
  44. 8.8.1 Vasudha Pharma Chem Company Information
  45. 8.8.2 Vasudha Pharma Chem Business Overview
  46. 8.8.3 Vasudha Pharma Chem Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vasudha Pharma Chem Loratadine API Product Portfolio
  48. 8.8.5 Vasudha Pharma Chem Recent Developments
  49. 8.9 Ultratech India Limited
  50. 8.9.1 Ultratech India Limited Company Information
  51. 8.9.2 Ultratech India Limited Business Overview
  52. 8.9.3 Ultratech India Limited Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ultratech India Limited Loratadine API Product Portfolio
  54. 8.9.5 Ultratech India Limited Recent Developments
  55. 8.10 Morepen
  56. 8.10.1 Morepen Company Information
  57. 8.10.2 Morepen Business Overview
  58. 8.10.3 Morepen Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Morepen Loratadine API Product Portfolio
  60. 8.10.5 Morepen Recent Developments
  61. 8.11 Inke, S.A.
  62. 8.11.1 Inke, S.A. Company Information
  63. 8.11.2 Inke, S.A. Business Overview
  64. 8.11.3 Inke, S.A. Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Inke, S.A. Loratadine API Product Portfolio
  66. 8.11.5 Inke, S.A. Recent Developments
  67. 8.12 Hetero Drugs Ltd
  68. 8.12.1 Hetero Drugs Ltd Company Information
  69. 8.12.2 Hetero Drugs Ltd Business Overview
  70. 8.12.3 Hetero Drugs Ltd Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hetero Drugs Ltd Loratadine API Product Portfolio
  72. 8.12.5 Hetero Drugs Ltd Recent Developments
  73. 8.13 Cadila Pharmaceuticals
  74. 8.13.1 Cadila Pharmaceuticals Company Information
  75. 8.13.2 Cadila Pharmaceuticals Business Overview
  76. 8.13.3 Cadila Pharmaceuticals Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cadila Pharmaceuticals Loratadine API Product Portfolio
  78. 8.13.5 Cadila Pharmaceuticals Recent Developments
  79. 8.14 Argon Drugs
  80. 8.14.1 Argon Drugs Company Information
  81. 8.14.2 Argon Drugs Business Overview
  82. 8.14.3 Argon Drugs Loratadine API Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Argon Drugs Loratadine API Product Portfolio
  84. 8.14.5 Argon Drugs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Loratadine API Value Chain Analysis
  2. 9.1.1 Loratadine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Loratadine API Production Mode & Process
  6. 9.2 Loratadine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Loratadine API Distributors
  9. 9.2.3 Loratadine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research